Clinical Trial: Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Head and Neck Cancer
Study Type: INTERVENTIONAL
Official Title: Characterizing Dynamics of FDG Uptake With Total-Body PET for Response Assessment in Radiotherapy for Head and Neck Cancer
Brief Summary:
The overall goal of this research study is to understand how 18F-fluorodeoxyglucose (FDG), a radioactive sugar behaves in head and neck cancer (HNC) and inflammation immediately following injection and at many hours post-injection, with the world's first total-body positron emission tomography (PET)/computed tomography (CT) scanner (EXPLORER).
Read more